Detection of Synchronous Parathyroid Adenoma and Breast Cancer with 18F-Fluorocholine PET-CT

被引:3
作者
Vorselaars W.M.C.M. [1 ]
Kluijfhout W.P. [1 ]
Vriens M.R. [1 ]
van der Pol C.C. [1 ]
Borel Rinkes I.H.M. [1 ]
Valk G.D. [2 ]
de Keizer B. [3 ]
机构
[1] Department of Oncological and Endocrine Surgery, University Medical Center Utrecht, Utrecht
[2] Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht
[3] Department of Nuclear Medicine and Radiology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht
关键词
Breast Cancer; Hyperparathyroidism; Papillary Carcinoma; Primary Hyperparathyroidism; Parathyroid Adenoma;
D O I
10.1007/s13139-015-0357-x
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:180 / 182
页数:2
相关论文
共 12 条
[1]  
Kluijfhout W.P., Vorselaars W.M., Vriens M.R., Et al., Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT, Eur J Radiol, (2015)
[2]  
Michaud L., Burgess A., Huchet V., Et al., Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?, J Clin Endocrinol Metab, 99, pp. 4531-4536, (2014)
[3]  
Lezaic L., Rep S., Sever M.J., Et al., <sup>18</sup>F-fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study, Eur J Nucl Med Mol Imaging, 41, pp. 2083-2089, (2014)
[4]  
Senkus E., Kyriakides S., Penault-Llorca F., Et al., Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 24, pp. vi7-vi23, (2013)
[5]  
Calderella C., Treglia G., Giordano A., Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis, Clin Breast Cancer, 14, pp. 241-248, (2014)
[6]  
Berg W.A., Zhang Z., Lehrer D., Et al., Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk, JAMA, 307, pp. 1394-1404, (2012)
[7]  
Dorrius M.D., de Vries E.F., Slart R.H., Et al., Breast cancer: a new imaging approach as an addition to existing guidelines, Eur J Nucl Med Mol Imaging, 42, pp. 813-817, (2015)
[8]  
Glunde K., Jie C., Bhujwalla Z.M., Molecular causes of the aberrant choline phospholipid metabolism in breast cancer, Cancer Res, 64, pp. 4270-4276, (2004)
[9]  
Contractor K.B., Kenny L.M., Stebbing J., Et al., [11C]choline positron emission tomography in estrogen receptor-positive breast cancer, Clin Cancer Res, 15, pp. 5503-5510, (2009)
[10]  
Kwee S.A., DeGrado T.R., Talbot J.N., Et al., Cancer imaging with fluorine-18-labeled choline derivatives, Semin Nucl Med, 37, pp. 420-428, (2007)